Single port laparoscopic right colonic resection using a 'vessel-first' approach

Aim Single port laparoscopic colorectal surgery (SPLC), performed through a single incision of ≤ 3 cm, has been shown to be feasible. This study aimed to assess its safety and efficacy when used as the method of choice for right hemicolectomy. Method A prospective study was carried out of patients undergoing right hemicolectomy using a single port laparoscopic technique. They were compared with a historical series of patients undergoing right hemicolectomy using a multiport laparoscopic technique. Between December 2009 and September 2010, single port surgery replaced conventional laparoscopic colorectal surgery (LCS) for radical medial to lateral right hemicolectomy performed by a single surgeon. Histology, length of hospital stay, complications, conversions and readmissions were recorded. Results Fourteen patients were treated using single port laparoscopic surgery (SPLC): 10 for carcinoma (Dukes A1, B6, C3) and four for Crohn’s disease. Twelve patients were treated using multiport laparoscopic colorectal surgery (LCS): eight for carcinoma (Dukes B4, C3, Carcinoid 1), three for Crohn’s disease and one for adenoma. The median (interquartile range) operative time for the SPLC group was 120 (90–135) min and for the LCS group was 135 (116–150) min. The median (interquartile range) length of hospital stay was 3.5 (2.0–5.0) days for the SPLC group and for the LCS group was 4.0 (3.8–7.0) days. The median (interquartile range) number of lymph nodes removed for SPLC patients was 14.5 (9.8–19.5) and for the LCS patients was 14.5 (13.0–19.5). There were no conversions, no complications and no readmissions in either group. Conclusion These data confirm the feasibility of the technique. Furthermore they suggest that it is safe and efficacious.     

Outcomes for case‐matched single‐port colectomy are comparable with conventional laparoscopic colectomy

Aim With the introduction of single‐port surgery, expected advantages are improved cosmesis, decrease of pain and shorter length of stay. The aim of this study was to compare early outcomes of single‐port colectomy with those of conventional laparoscopic colectomy. Method All consecutive patients undergoing single‐port colectomy between January and June 2010 were identified from a prospective database. They were matched for age, sex, body mass index, American Society of Anesthesiology score and type of resection with patients who had conventional laparoscopic colectomy. All perioperative data, analgesic requirement, pain scores and inflammatory response were compared using the Wilcoxon signed‐rank and McNemar tests. Results Fourteen patients [five men, nine women; median age (interquartile range) 56 (30–73) years, body mass index (interquartile range) 22 (20–24) kg/m²] underwent single‐port colectomy and were matched with patients who had conventional laparoscopic colectomy. Median operating times, estimated blood loss, pain scores, analgesic requirement, inflammatory response and length of hospital stay were similar. Median increase in incision length was significantly higher in the single‐port group (P = 0.004), but maximal incision length for specimen extraction was comparable. There were no anastomotic leaks, wound infections or 30‐day readmissions. Conclusion In a case‐matched setting with a small sample size, single‐port laparoscopic colectomy has comparable outcomes to conventional laparoscopic colectomy.     

后腹腔镜下肾癌根治术65例临床疗效分析

目的 评价后腹腔镜肾癌根治手术临床疗效,总结手术经验.方法 回顾性分析2006年6月至2010年12月65例后腹腔镜肾癌根治性切除术患者的临床资料.结果 65例手术均获成功,手术平均时间90.2±34.6 min,平均出血量80.1±28.5 ml,术后住院时间平均7.0±2.3 d;11例腹膜破裂,1例误伤下腔静脉,术中钛夹夹闭止血,夹闭下腔静脉腔1/3,术后无并发症发生.随访6~48个月,未见肿瘤复发及转移.结论 后腹腔镜肾癌根治术具有创伤小、出血少、恢复快的优点,是一种安全、有效的治疗方法,具有良好的临床应用前景.     

单孔腹腔镜肾囊肿去顶术与传统腹腔镜手术的对比研究

目的比较单孔腹腔镜与传统腹腔镜肾囊肿去顶术的手术效果,总结单孔腹腔镜肾囊肿去顶术的手术经验。方法自2010年1月至2011年3月,我院收治单纯肾囊肿患者30例,随机分为两组,其中采用自制单孔多通道腹腔镜肾囊肿去顶术15例,传统腹腔镜手术去顶术15例,所有手术均为同一位外科医师主刀,比较两组的手术时间、术中出血量及近期随访手术疗效。结果 30例手术均获成功,两组术中均无明显并发症发生。传统腹腔镜与单孔腹腔镜在手术时间(63.5minvs52.5min,P=0.104)、术中出血量(20mlvs25ml,P=0.721),术后住院时间(4.3dvs4.9d,P=0.647)无统计学差异。结论在取得一定腹腔镜手术经验的单位,单孔多通道腹腔镜是安全可行的,其与传统腹腔镜肾囊肿去顶术相比,并不明显增加手术时间。     

经脐单孔与多孔法腹腔镜手术治疗贲门失弛缓症及食管裂孔疝的比较研究

目的 探讨经脐单孔腹腔镜手术治疗贲门失弛缓症及食管裂孔疝的安全性和可行性.方法 2008年1月至2011年12月,行腹腔镜手术治疗贲门失弛缓症及食管裂孔疝患者17例.其中,单孔法组7例,多孔法组10例.收集两组围手术期资料进行比较分析.结果 全部患者均顺利完成腹腔镜手术.单孔组手术时间115 ～ 180 min,出血量50～110ml,术后住院时间5～7d;多孔组手术时间100～ 155 min,出血量40～ 90 ml,住院时间5～9d.所有患者均无术后出血、食管漏、发热感染等并发症发生.单孔组患者术后脐部切口愈合良好,美容效果明显.结论 对于有经验的腹腔镜外科医师,单孔腹腔镜手术治疗贲门失弛缓症及食管裂孔疝是安全可行的,并具有极佳的美容效果.其临床应用价值仍需进一步研究证实.     

腹腔镜辅助阴式切除盆腔后部深部浸润型 子宫内膜异位症全子宫的方法改良

目的 探讨采用改良后腹腔镜辅助阴式子宫切除术切除严重子宫内膜异位症全子宫的疗效。方法 选择同期由同一手术医师进行的常规腹腔镜辅助阴式子宫切除术与改良后腹腔镜辅助下阴式子宫切除术的病例98例,其中,常规腹腔镜辅助阴式子宫切除术46例,改良后腹腔镜辅助下阴式子宫切除术52例,比较两组的手术时间、术中出血量、手术并发症、肛门排气时间、术后病率及术后住院天数。结果 常规组手术时间（122.4±28.6）min,改良组为（102.2±38.4）min,两组比较差异有显著性,P <0.05;常规组术中出血量为（234.4±102.6）mL,改良组为（222.4±111.8）mL,两组比较差异无显著性,P >0.05。常规组中转开腹3例,改良组无1例中转开腹,两组均无手术并发症。结论 采用改良后的方法,提高了严重子宫内膜异位症患者腹腔镜下经阴道子宫切除手术的安全性及成功率,扩大了腹腔镜的手术指征。     

腹腔镜治疗异位妊娠临床疗效分析

目的 探讨对异位妊娠患者采用腹腔镜手术治疗的临床治疗效果.方法 选取我院异位妊娠病例200例,随机分为观察组和对照组各100例,对观察组采用腹腔镜手术治疗,对照组则采用开腹手术治疗,对比分析2组患者的临床治疗效果,分析2组患者手术效果及手术并发症等指标.结果 观察组术中没有出现中转开腹和直肠膀胱损伤的病例,术后均恢复良好,疼痛感明显减轻,镇痛处理病例明显减少.2组手术时间基本相等,而2组在术后下床时间、肛门排气时间、住院时间以及术中出血量方面比较差异显著,具有统计学意义(P＜0.05).结论 应用腹腔镜治疗异位妊娠对机体内环境干扰较少,出血量少且术后恢复快,具有快速、微创、时间短及恢复快等优点,明显优于传统开腹手术,值得进行临床推广应用.     

后腹腔镜与开放手术治疗肾上腺肿瘤的比较分析

目的 比较分析后腹腔镜与开放手术治疗肾上腺肿瘤的临床疗效.方法 回顾性分析该院2009年2月-2011年6月收治的肾上腺肿瘤患者50例,将其随机分为两组,其中25例为实验组行后腹腔镜术式,剩余25例为对照组行开放手术治疗,比较分析两组患者的术中和术后情况.结果 实验组平均手术时间以及术中平均出血量都明显小于对照组,并且术后实验组卧床时间和肠道功能恢复时间均明显小于对照组,差异均具有统计学意义(P＜0.05).结论 后腹腔镜与开放手术治疗肾上腺肿瘤比较,行腹腔镜手术的患者术中和术后情况均好于行开放手术的患者,值得在临床上推广.     

腹腔镜辅助阴式子宫广泛切除术在子宫恶性肿瘤中应用的临床疗效

目的探讨腹腔镜辅助阴式子宫广泛切除术(LARVH)在子宫恶性肿瘤中的临床疗效。方法选择2010年10月至2011年10月本院收治的20例子宫恶性肿瘤患者为研究对象,对其行LARVH+盆腔淋巴结清扫术(LARVH组)。随机抽取2009年5月至2011年10月因子宫恶性肿瘤行传统开腹手术的38例患者纳入对照组(本研究遵循的程序符合本院人体试验委员会制定的伦理学标准,得到该委员会批准,分组征得受试对象本人的知情同意,并与之签署临床研究知情同意书)。采用统计学方法分析手术疗效、患者术后恢复及随访情况。结果 LARVH组20例患者手术顺利,术中出血量为(150～350)mL,术后肛门排气时间为(1.0～2.5)d,术后盆腔引流量为(125～350)mL,膀胱功能恢复所需时间为(12～30)d,住院时间为(14～20)d,术后拆线时间为(5～7)d,以上临床资料与对照组比较,差异均有统计学意义(P<0.05)。所有患者术后第2天均可下地活动,无一例伤口出现脂肪液化感染。LARVH组手术时间[(210～320)min]、阴道切除长度[(3.0～4.0)cm]方面与对照组比较,差异均无统计学意义(P>0.05)。对LARVH组患者随访(3～14)个月显示,术后残端愈合良好,无一例复发及并发症发生。结论 LARVH在子宫恶性肿瘤中的应用是否切实可行,尚需大样本、多中心前瞻性随机对照研究进一步研究证实。